In this trial of patients with 3-4+ mitral regurgitation, patients were randomized to traditional surgical repair, or percutaneous repair. Percutaneous repair was more likely to result in the primary outcome at 1 year (death, need for surgery for mitral valve dysfunction, or recurrent 3-4+ regurgitation), but less likely to result in a major adverse events (15% vs 48%). Percutaneous repair may be a very good option for mitral valve regurgitation in some patients (abstract)
Share This Post
Categories
Related Posts
Never let a good salary signal go to waste. Here is a meta-assembly of hospitalist, as well as comparator specialties, of 2018-19 salary moves courtesy of Modern Healthcare. It is useful seeing the various estimates from the leading consultants, placement firms, and intelligentsia to get some bearings on the pay trends, Covid notwithstanding.
This is the time of year to sit back at night, in front of the fireplace, a cup of hot chocolate in hand, warming up after the coolness of the day. As I sip, I notice the marshmallows bobbing up and down and reflect on the impact those white confections have in medicine. Yes, marshmallows […]
Look up from your stack of journals lately? You will note DNA analysis has gotten awfully popular. Mom, dad, and the rest of the clan want in and the temptation to obtain the blueprint that makes you, you has an almost hypnotic-like draw. You are curious if what grandma told you—half of your “G, C, […]
Leave A Comment